About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5556107
Allelic
Composition		 Gt(ROSA)26Sortm2(CAG-Dsred2/EGFP)Luo/Gt(ROSA)26Sortm1(Notch3*)Sfr
Notch3tm1.1(cre/ERT2)Sat/Notch3+
Genetic
Background		 involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(Notch3*)Sfr mutation (0 available); any Gt(ROSA)26Sor mutation (1095 available)
Gt(ROSA)26Sortm2(CAG-Dsred2/EGFP)Luo mutation (2 available); any Gt(ROSA)26Sor mutation (1095 available)
Notch3tm1.1(cre/ERT2)Sat mutation (0 available); any Notch3 mutation (95 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
endocrine/exocrine glands
decreased mammary gland epithelial cell proliferation ( J:201985 )
• following 4 weeks of tamoxifen treatment clonal expansion of cre expressing cells is markedly reduced

cellular
decreased mammary gland epithelial cell proliferation ( J:201985 )
• following 4 weeks of tamoxifen treatment clonal expansion of cre expressing cells is markedly reduced

integument
decreased mammary gland epithelial cell proliferation ( J:201985 )
• following 4 weeks of tamoxifen treatment clonal expansion of cre expressing cells is markedly reduced

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
03/18/2025
MGI 6.24 		The Jackson Laboratory